Showing 71-80 of 3844 results for "".
Noah Worcester 2024: Dr. Bhatia on Actinic Keratosis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bhatia-actinic-keratosis/24585/Neal Bhatia, MD, FAAD, summarizes his lecture on actinic keratosis and photodynamic therapy at the 2024 Noah Worcester Dermatological Society meeting.Noah Worcester 2024: Dr. Greenberg on the Society
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-greenberg-society/24588/Michael Greenberg, MD, president of the Noah Worcester Dermatological Society, speaks at the organization’s 2024 meeting about what makes the event special.Skin Biopsy for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/tbd/48782/James Q. Del Rosso, DO, FAOCD, discusses situations in which histopathology can help to correctly diagnose prurigo nodularis.A Case Presentation of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37154/Alina Bridges, DO, Director of Dermatopathology & Associate Professor in the Department of Dermatology and Anatomic Pathology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, presents a case study involving a patient who had been on multiple treatments to present prurituNoah Worcester 2024: Dr. Adams on Sports Dermatology
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-adams-sports-dermatology/24584/Brian Adams, MD, MPH, summarizes his lecture on treating professional athletes at the 2024 Noah Worcester Dermatological Society meeting.DermWireTV: Novan EPI Acquisition, Champions for Change Gala, Mt. Sinai Alopecia Center
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-novan-epi-acquisition-champions-for-change-gala-mt-sinai-alopecia-center/20070/EPI Health is now a Novan company; the combined company will employ approximately 100 staff. Novan’s lead candidate, berdazimer gel 10.3%, performed well in a phase 3 study for the treatment of molluscum contagiosum. The Skin Cancer Foundation is gearing up for its signature fundraising event: The CAllergan Acquires Vitae, PsA Day, Novan News
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-allergan-acquires-vitae-psa-day-novan-news/18572/Allergan is acquiring clinical-stage biotechnology company Vitae Pharmaceuticals for $21.00 per share, in cash, for a total transaction value of approximately $639 million. Novan has launched its initial public offering and is now listed on the NASDAQ. Celgene Corporation and the National PsoriasisUsing Fillers in the Nose
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/using-fillers-in-the-nose/19204/Steven Dayan, MD, talks about the use of fillers in the nose for temporary cosmetic improvement or to tweak surgical outcomes.Treating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.Noah Worcester 2024: Dr. Gold on Toxins
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gold-toxins/24583/Noah Worcester 2024: Dr. Gold on Toxins